FCP
DXCM icon

Fidelis Capital Partners’s DexCom DXCM Stock Holding History

Fidelis Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,399
Closed -$209K – 441
2024
Q4 		$209K Buy
+2,399
New +$178K 0.02% 415
2024
Q2 		– Sell
-1,717
Closed -$238K – 383
2024
Q1 		$238K Buy
+1,717
New +$216K 0.04% 330

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelis Capital Partners's DXCM Position: Q1 2025 in Review

Fidelis Capital Partners sold out of DexCom (DXCM) in Q1 2025, closing a stake of 2,399 shares — an estimated $209K sold.

Fidelis Capital Partners first reported a position in DXCM in Q1 2024 and held it in 2 quarters. The position peaked at $238K in Q1 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

  • Fidelis Capital Partners reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
  • Fidelis Capital Partners sold 2,399 DexCom shares in Q1 2025, an estimated $209K.
  • Fidelis Capital Partners first reported a position in DexCom in Q1 2024 and held it in 2 quarters.
  • Fidelis Capital Partners's DexCom position peaked at $238K in Q1 2024.
  • 932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Fidelis Capital Partners's 13F filing for Q1 2025, filed 1 May 2025.